Skip to content

BRC stock

BRCCNYSE

BRC Inc., Consumer DefensiveISIN US05601U2042

$9.60▼ $0.49 (−4.9%)Closing price of 12 Nov 2026

29Score 29 out of 100, Weak

Turn on early warning

Price and trend

39 / 100

Price history

−26% in one year

The chart shows daily closes over 6 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 6.4% below it.

Trend change

Since August 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 37).

Distance to the high

The price is 46% below its 52-week high. Largest decline in 6 years: 98% (April 2022 to February 2026).

Chart figures for advanced users
SMA 50$9.88
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$10.25
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)37
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDbelow the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$6.25
The lowest closing price of the last twelve months.
Resistance$17.80
The highest closing price of the last twelve months.
Market cap
$312.79M
Div. yield
no dividend
Loss
Fair value
no data

Snapshot

Computed from the data by fixed rules, no AI

  • BRC Inc. belongs to the Packaged Foods industry (United States) and, with a market value of $312.79M, is number 76 of 76 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $398.26M (up 1.7% year on year) and a loss of $11.91M.
  • MEQIRI Score 29 out of 100 (Weak): rank 295 of 296 in Consumer Defensive, median 62.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Growing faster than its industryRevenue up 19.4% a year since 2020, Packaged Foods median 5.4%.Growth 56

Weaknesses

  • DilutionShare count up 86% since 2022.Capital allocation 9
  • Loss-makingLoss of $6.68M over the last 12 months.Fundamentals 18
  • Negative free cash flowFree cash flow −$613K over the last 12 months.Fundamentals 18
29/ 100
MEQIRI Score
Weak

The score is held back by momentum and capital allocation.

Daily figure as of 13 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 32 to 29.

Fundamental quality fluctuates.

Profit consistency14% of years
Cash conversion (free cash flow to earnings, 12 months)not measured
ROIC (12 months)−8.0%
Positive free cash flow43% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Valuation

Valuation signal

not measured
Price
$9.60
Fair value
not computable
Gap to fair value
no data

No fair value can be calculated for this stock, so the signal follows the valuation grade.

Valuation metrics

no data
no data
Fair value (model)
no data

No fair value can be calculated for this stock from the available figures.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

7 years

In the twelve months to 30 Sep 2026, revenue rose 11.7% on the twelve months before. Revenue has grown strongly since 2019, at around 30% per year.

Margins

7 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 35%, operating −6%, net −3%.

Debt & balance sheet

latest quarter
0.68
−3.3x
1.59
Cash & equivalents
$9.2M

Debt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
8 Mar 2027in 115 days
Last reported
2 Nov 2026EPS reported −$0.28 (expected $0.06)below expectations

Analyst estimates

Fiscal 20261 analyst
Earnings per share
−$0.37−300.0%
Revenue
$430.55M−0.4%
Fiscal 20271 analyst
Earnings per share
$0.75−8.0%
Revenue
$447.98M−4.1%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook raised

Share price after the results: +15.6%

2026 revenue outlook raised to at least 8% growth, adjusted EBITDA guidance raised to at least 35% growth (from at least 30%).

Supporting passage from the call, verbatim
“We're also increasing our adjusted EBITDA guidance to at least 35% growth or approximately $29 million, up from our prior outlook of at least 30% growth.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 5 May 2026 (fiscal Q1 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. One insider sold, $532,325 in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Hafer EvanSale

    28 Oct 2026, 10 percent owner, officer: Founder

    Shares
    12,000
    Price
    $11.78
    Value
    $141,343
  • Hafer EvanSale

    27 Oct 2026, 10 percent owner, officer: Founder

    Shares
    12,000
    Price
    $11.37
    Value
    $136,483
  • Hafer EvanSale

    20 Oct 2026, 10 percent owner, officer: Founder

    Shares
    5,572
    Price
    $10.59
    Value
    $59,003
Show 4 more
  • Hafer EvanSale

    16 Oct 2026, 10 percent owner, officer: Founder

    Shares
    2,724
    Price
    $10.56
    Value
    $28,765
  • Hafer EvanSale

    15 Oct 2026, 10 percent owner, officer: Founder

    Shares
    15,304
    Price
    $10.62
    Value
    $162,528
  • Hafer EvanSale

    14 Oct 2026, 10 percent owner, officer: Founder

    Shares
    200
    Price
    $10.50
    Value
    $2,100
  • Hafer EvanSale

    13 Oct 2026, 10 percent owner, officer: Founder

    Shares
    200
    Price
    $10.51
    Value
    $2,102

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at BRC

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

296 rated companies in Consumer Defensive

Rank 295 of 296
295/ 296
This company
29
Sector median
62

Categories against the sector medianMedian of 296 companies

Profitability19 (median 54)35 below the median
Growth56 (median 50)6 above the median
Fundamentals18 (median 79)61 below the median
Stability43 (median 68)25 below the median
Capital allocation9 (median 62)53 below the median
Technical analysis39 (median 64)25 below the median
Momentum17 (median 59)42 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Packaged Foods

The next larger companies by market value

All 76 Packaged Foods stocks

ETFs that hold BRC

Held by 2 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
Xtrackers Russell 2000 UCITS ETF 1CXRS20.00%0.30%€2.22B
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR0.00%0.30%€4.28B

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 28 Feb 2023)
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy